Lhasa Limited shared knowledge shared progress
Loading...
PublicationsJump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
TitlePublishedTypeProducts
Developing an adverse outcome pathway framework for carcinogenicity from alerts in an expert rule-based systemSeptember 2018pdf fileDerek Nexus
Vitic 3.1 Release NotesSeptember 2018pdf fileVitic Nexus
A Defined Approach to Skin Sensitisation: Integrating Derek Nexus with In Chemico/In Vitro Assays Based on Exclusion CriteriaAugust 2018pdf fileDerek Nexus
Mirabilis - A Simple, Annotated DemonstrationAugust 2018Mirabilis
Elemental Impurities 2018.1.0 Release NotesJuly 2018pdf file
Aromatic Amines 2018.1.0 Release NotesJuly 2018pdf fileVitic Nexus
Vitic - A Faster, More Efficient Searching ExperienceJuly 2018Vitic Nexus
Elemental Impurities Data Sharing InitiativeJuly 2018pdf fileVitic Nexus
Sharing Elemental Impurity Data for Excipients Aids ICH Q3D Risk AssessmentsJune 2018pdf file
Applicability Domain: Towards a more formal definitionJune 2018pdf file
Applicability domain and confidence in predictions: Towards a more formal frameworkJune 2018pdf file
Elemental Impurities Database for ExcipientsJune 2018pdf file
Vitic 2018.1.0 Release NotesJune 2018pdf fileVitic Nexus
A pharma-wide approach to address the genotoxicity prediction of primary aromatic amines.June 2018
Perspectivas Regulatórias sobre a Qualificação de Produtos de Degradação e ImpurezasJune 2018pdf file
ICH M7 Overview: Predicting, Assessing, and Controlling Mutagenic Impurities from DegradationJune 2018pdf file
Use of In Silico for Assessing DegradantsJune 2018pdf fileZeneth
Supporting Lhasa Members in a Regulatory SettingJune 2018pdf file
Mirabilis: Using Mirabilis to Support Purge Arguments Under ICH M7June 2018pdf fileMirabilis
Miniaturization of the Ames test MPAJune 2018pdf file
Mutagenicity Predictions using a Statistical SystemJune 2018pdf fileSarah Nexus
Toxicity Studies for Degradation Impurities - An Industry PerspectiveJune 2018pdf fileDerek NexusSarah Nexus
How Zeneth fits into ICH Q3DJune 2018pdf fileZeneth
Improving Toxicity Predictions through knowledge and data sharingJune 2018pdf fileDerek NexusExcipientsIntermediatesiPiEVitic Nexus
ICH M7 Use CasesJune 2018pdf fileDerek NexusSarah Nexus

© 2019 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.